Biological plausibility between proton pump inhibitory therapy and hip fracture: hyperhomocysteinemia can be the link

Am J Gastroenterol. 2009 Apr;104(4):1052. doi: 10.1038/ajg.2008.175. Epub 2009 Feb 24.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Female
  • Gastroesophageal Reflux / blood
  • Gastroesophageal Reflux / drug therapy
  • Hip Fractures / blood
  • Hip Fractures / epidemiology
  • Hip Fractures / etiology*
  • Homocysteine / blood*
  • Humans
  • Hyperhomocysteinemia / blood
  • Hyperhomocysteinemia / complications*
  • Hyperhomocysteinemia / epidemiology
  • Incidence
  • Male
  • Proton Pump Inhibitors / adverse effects*
  • Proton Pump Inhibitors / therapeutic use
  • Risk Factors
  • Vitamin B 12 Deficiency / blood
  • Vitamin B 12 Deficiency / complications
  • Vitamin B 12 Deficiency / epidemiology

Substances

  • Proton Pump Inhibitors
  • Homocysteine